Economic analysis of expensive technologies: the case of erythropoietin.
Griggs
J J
JJ
Mushlin
A I
AI
D000740:Anemia / Q000139:chemically induced / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D004921:Erythropoietin / Q000191:economics* / Q000627:therapeutic use; D006301:Health Services Needs and Demand; D006801:Humans; D019057:Quality-Adjusted Life Years
D004921:Erythropoietin